These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12060086)

  • 1. Metastatic astrocytoma in the parotid.
    Raut V; Golchin K; Anderson N; Primrose WJ
    Cytopathology; 2002 Jun; 13(3):186-8. PubMed ID: 12060086
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-Fluorouracil, adriamycin, cyclophosphamide (FAC) vs. 5-fluorouracil, epirubicin, cyclophosphamide (FEC) in metastatic breast cancer.
    Lopez M; Papaldo P; Di Lauro L; Vici P; Carpano S; Conti EM
    Oncology; 1989; 46(1):1-5. PubMed ID: 2915887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose adjuvant chemotherapy for patients with high-risk breast cancer: efficacy is still an open question.
    Clin Breast Cancer; 2000 Oct; 1(3):191-2. PubMed ID: 11899643
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of primary brain tumors.
    Levin VA
    Neurol Clin; 1985 Nov; 3(4):855-66. PubMed ID: 3001491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: a dose-finding study.
    Nagel GA; Beyer JH; Holtkamp W; Emrich D; Kneba M; Luig H; Marschner N; Rauschning W; Unger C; Wander HE
    Onkologie; 1988 Dec; 11(6):287-8. PubMed ID: 3071764
    [No Abstract]   [Full Text] [Related]  

  • 6. [5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in adenocarcinoma of the parotid gland].
    Inoue K; Horikoshi N; Mukaiyama T; Ogawa M; Kuraishi Y
    Gan No Rinsho; 1989 Mar; 35(4):481-5. PubMed ID: 2654442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.
    de Azambuja E; Ameye L; Diaz M; Vandenbossche S; Aftimos P; Bejarano Hernández S; Shih-Li C; Delhaye F; Focan C; Cornez N; Vindevoghel A; Beauduin M; Lemort M; Paesmans M; Suter T; Piccart-Gebhart M
    Eur J Cancer; 2015 Nov; 51(17):2517-24. PubMed ID: 26321502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of advanced male breast cancer successfully treated by 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy combined with tamoxifen.
    Tanaka Y; Ohmori Y; Toki T; Okazaki Y; Ogoshi S; Ogawa Y
    Nihon Geka Hokan; 1995 Jan; 64(1):15-22. PubMed ID: 8534185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The interesting case No. 43].
    Arweiler-Harbeck D; Bremkamp S
    Laryngorhinootologie; 2001 Mar; 80(3):166-8. PubMed ID: 11320881
    [No Abstract]   [Full Text] [Related]  

  • 10. Different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil: a randomised study in advanced breast cancer.
    Riccardi A; Giordano M; Brugnatelli S; Ucci G; Danova M; Mora O; Fava S; Ascari E
    Eur J Cancer; 1995; 31A(9):1549-51. PubMed ID: 7577090
    [No Abstract]   [Full Text] [Related]  

  • 11. Mammary invasive duct carcinoma metastatic to parotid gland: report of a case diagnosed by fine-needle aspiration.
    Laforga JB; Gasent JM
    Diagn Cytopathol; 2009 Feb; 37(2):154-8. PubMed ID: 19030187
    [No Abstract]   [Full Text] [Related]  

  • 12. The cardioprotector ADR-529 and high-dose epirubicin given in combination with cyclophosphamide, 5-fluorouracil, and tamoxifen: a phase I study in metastatic breast cancer.
    Sørensen B; Bastholt L; Mirza MR; Gjedde SB; Jakobsen P; Mouridsen HT; Rose C
    Cancer Chemother Pharmacol; 1994; 34(5):439-43. PubMed ID: 8070013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is extracranial metastatic malignant glioma iatrogenic?].
    Megele R; Gruss P; Bührmann K
    Neurochirurgia (Stuttg); 1989 Sep; 32(5):157-9. PubMed ID: 2552337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent tamoxifen (TAM) + cyclophosphamide, epirubicin, and fluorouracil (CEF) versus TAM + delayed CEF after six months of endocrine therapy in metastatic breast cancer--a randomized trial from the Danish Breast Cancer Cooperative Group (DBCG).
    Pfeiffer P; Rose C; Ejlertsen B; Andersson M; Pedersen D; Mouridsen HT
    Acta Oncol; 1996; 35 Suppl 5():57. PubMed ID: 9142967
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy in the treatment of brain metastases of breast cancers].
    Couteau C; Chevallier B; Bastit P
    Bull Cancer; 1994 Mar; 81(3):226-9. PubMed ID: 7894132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-irradiation chemotherapy for newly diagnosed high grade astrocytoma.
    Mathieu NT; Genet D; Labrousse F; Bouillet P; Denes SL; Martin J; Labourey JL; Venat L; Clavere P; Moreau JJ
    Anticancer Res; 2004; 24(2C):1249-53. PubMed ID: 15154655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of advanced cancer of the breast with FEC polychemotherapy using epirubicin at 75 mg/m2 dose (FEC 75)].
    Perez Carrion R; Jimeno JM; Jimenez V; Guardiola L; Donnay O; Sanchez J
    Bull Cancer; 1990; 77(10):1033-5. PubMed ID: 2249014
    [No Abstract]   [Full Text] [Related]  

  • 18. Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group.
    Del Mastro L; Venturini M; Lionetto R; Carnino F; Guarneri D; Gallo L; Contu A; Pronzato P; Vesentini L; Bergaglio M; Comis S; Rosso R
    J Clin Oncol; 2001 Apr; 19(8):2213-21. PubMed ID: 11304774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokinetic-based versus conventional chemotherapy in metastatic breast cancer: a randomized study.
    Conte PF; Rubagotti A; Falcone A; Gardin G; Nicolin A; Pronzato P; Rosso R; Amadori D; Gentilini P; Sismondi P
    Chemioterapia; 1987 Jun; 6(2 Suppl):712-3. PubMed ID: 3334664
    [No Abstract]   [Full Text] [Related]  

  • 20. Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM).
    Colucci G; Romito S; Gebbia V; Pacilio G; Giotta F; Testa A; Pezzella G; Durini E; Agostara B; Cariello S
    Br J Cancer; 1995 Nov; 72(5):1245-50. PubMed ID: 7577476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.